pyrrolidine dithiocarbamate has been researched along with Ventricular Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, S; Luo, Y; Sun, X; Zeng, K; Zhang, F; Zhong, S | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Ventricular Dysfunction
| Article | Year |
|---|---|
Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats.
Topics: Animals; Coronary Thrombosis; Disease Models, Animal; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocardium; NF-kappa B; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiocarbamates; Tumor Necrosis Factor-alpha; Ventricular Dysfunction | 2010 |